Regulation of selection of liver nodules initiated with N- nitrosodiethylamine and promoted with nodularin injections in Fischer 344 male rats by reciprocal expression of transforming growth factor-β1 and its receptors

Molecular Carcinogenesis

Volumn 26, Issue 2, 1999, Pages 83-92

  Lim, In Kyoung ^a   Park, Sang Chul ^b   Song, Kye Yong ^c   Park, Tae Jun ^a   Lee, Myung Soog ^a   Kim, Seong Jin ^d   Hyun, Byung Hwa ^e  

^a Ajou University School of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Res Inst of Biosci and Biotech   (South Korea)

Author keywords

Glutathione s transferase placental form; Hepatocarcinogenesis; Liver regeneration; Transforming growth factor receptors

Indexed keywords

DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; NODULARIN; RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; LIVER HYPERPLASIA; LIVER REGENERATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR GROWTH; TUMOR REGRESSION;

ALKYLATING AGENTS; ANIMALS; BLOTTING, NORTHERN; DIETHYLNITROSAMINE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE TRANSFERASE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KINETICS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PEPTIDES, CYCLIC; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0003069139     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199910)26:2<83::AID-MC3>3.0.CO;2-4     Document Type: Article

References (41)

1. Massague J. The transforming growth factor-beta family. Ann Rev Cell Biol 1990;6:597-641.
2. Roberts AB, Sporn MB. Mechanistic interrelationships between two superfamilies: The steroid/retinoid receptors and transforming growth factor-β. Cancer Surv 1992; 14:205-220.
3. Sporn MB, Roberts AB. Transforming growth factors-β: Recent progress and new challenges. J Cell Biol 1992;119: 1017-1021.
4. Pircher R, Lawrence DA, Jullien P. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells clone 49F. Cancer Res 1984;44:5538-5543.
5. Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 1987;105: 965-975.
6. Roberts AB, Flanders KC, Kondaiah P, et al. Transforming growth factor-β: Biochemical role in embryogenesis, tissue repair and remodeling, and carcinogenesis. Recent Prog Horm Res 1988;44:157-197.
7. Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor β requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 1991;88: 580-584.
8. Derynck R, Jarrett JA, Chen EY, et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-705.
9. Bassing CH, Yingling JM, Howe DJ, et al. A transforming growth factor β type I receptor that signals to activate gene expression. Science 1994;263:87-89.
10. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase, Cell 1992;68: 775-785.
11. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J, Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-347.
12. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor β mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 1988;85: 1539-1543.
13. Jirtle RL, Carr BI, Scott CD. Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-β1 during liver regeneration. J Biol Chem 1991;266:22444-22450.
14. Ito N, Kawata S, Tamura S, et al. Elevated levels of transforming growth factor β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 1991;51:4080-4083.
15. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. Transforming growth factor-beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 1995;21:760-766.
16. Sue SR, Chari RS, Kong FM, et al. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg 1995;222:171-178.
17. Inagaki M, Moustakas A, Lin HY, Lodish HF, Carr BI. Growth inhibition by transforming growth factor β(TGF-β) type I is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc Natl Acad Sci USA 1993;90:5359-5363.
18. Carmichael WW, Eschedor JT, Patterson GM, Moore RE. Toxicity and partial structure of a hepatotoxic peptide produced by the cyanobacterium Nodularia spumigena Mertens emend. L575 from New Zealand. Appl Environ Microbiol 1988;54:2757-2763.
19. Nishiwaki-Matsushima R, Ohta T, Nishiwaki S, et al. Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J Cancer Res Clin Oncol 1992;118: 420-424.
20. Sueoka E, Sueoka N, Okabe S, et al. Expression of the tumor necrosis factor α gene and early response genes by nodularin, a liver tumor promoter, in primary cultured rat hepatocytes. J Cancer Res Clin Oncol 1997;123: 413-419.
21. Ohta T, Sueoka E, Iida N, et al. Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male Fischer 344 rat liver. Cancer Res 1994;54:6402-6406.
22. Song KY, Lim IK, Pari SC, et al. Effect of nodularin on the expressions of glutathione-s-transferase placental form and proliferating cell nuclear antigen in N-nitrosodiethylamine initiated hepatocarcinogenesis in the male Fischer 344 male rat. Carcinogenesis, 1999;20:1541-1548.
23. Kwak S-J, Park SC. Purification and characterization of glutathione s-transferase p from human placental tissues. Seoul Journal of Medicine 1988;29:107-118.
24. Flanders KC, Thompson NL, Cissel DS, et al. Transforming growth factor-β1: Histochemical localization with antibodies to different epitopes. J Cell Biol 1989;108: 653-660.
25. Kim IY, Ahn HJ, Zelner DJ, et al. Loss of expression of transforming growth factor beta type I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin Cancer Res 1996;2:1255-1261.
26. Lim IK, Lee MS, Lee SH, et al. Differential expression of TIS21 and TIS1 genes in the various organs of BALB/c mouse, thymic carcinoma tissues and human cancer cell lines. J Cancer Res Clin Oncol 1995;121:279-284.
27. Stenius U. Different inhibition of DNA synthesis by transforming growth factor β and phenobarbital on GST-P-positive and GST-P-negative hepatocytes. Carcinogenesis 1993;14:159-161.
28. Jirtle RL, Hankins GR, Reisenbichler H, Boyer IJ. Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis 1994;15: 1473-1478.
29. Reisenbichler H, Chari RS, Boyer IJ, Jirtle RL. Transforming growth factor-β receptors type I, II, and III in phenobarbital-promoted rat liver tumors. Carcinogenesis 1994;115: 2763-2767.
30. Mansbach JM, Mills JJ, Boyer IJ, De Souza AT, Hankins GR, Jirtle RL. Phenobarbital selectively promotes initiated cells with reduced TGF-β receptor levels. Carcinogenesis 1996;17:171-174.
31. Monser GJ, Wolf DC, Harden R, et al. Cell proliferation and regulation of negative growth factors in mouse liver foci. Carcinogenesis 1996;17:1835-1840.
32. Factor VM, Kao CY, Santoni-Rugiu E, Woitach JT, Jensen MR, Thorgeirsson SS. Constitutive expression of mature transforming growth factor β1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Cancer Res 1997; 57:2089-2095.
33. Sargent LM, Dragon Y, Erickson C, Laufer CJ, Pitot HC. Study of the separate and combined effects of the nonplanar 2,5,2′5′-and the planar 3,4,3′4′-tetrachlorobiphenyl in liver and lymphocytes in vivo. Carcinogenesis 1991;12:793-800.
34. Sargent LM, Sattler GL, Roloff B, et al. Ploidy and specific karyotypic changes during promotion with phenobarbital, 2,5,2′5′-tetrachlorobiphenyl, and/or 3,4,3′ 4′-tetrachlorobiphenyl in rat liver. Cancer Res 1992;52: 955-962.
35. Sargent LM, Dragon Y, Xu Y-H, Sattler G, Wiley J, Pitot HC. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat. Cancer Res 1996;56: 2985-2991.
36. Yamada J, Kuramoto T, Serikawa T. A rat genetic linkage map and comparative maps for mouse or human homologous rat genes. Mamm Genome 1994;5:63-83.
37. Oberhammer FA, Pavelka M, Sharma S, et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci USA 1992;89:5408-5412.
38. Schulte-Hermann R, Bursch W, Kraupp-Grasl B, Oberhammer F, Wagner A. Programmed cell death and its protective role with particular reference to apoptosis. Toxicol Lett 1992;64-65 Spec No: 569-574.
39. Bursch W, Oberhammer F, Jirtle RL, et al. Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br J Cancer 1993;67:531-536.
40. Oberhammer F, Bursch W, Tiefenbacher R, et al. Apoptosis is induced by transforming growth factor-beta 1 within 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology 1993;8:1238-1246.
41. Grasl-Kraupp B, Rossmanith W, Ruttkay-Nedecky B, et al. Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia. Hepatology 1998; 28:717-726.